Haleon HLN
NYSE HLN
$9.82 -0.05 (-0.51%)
At close: Aug 20, 2026 · 9:42 AM UTC

Haleon (HLN) EBITDA Margin Growth (1y) (2022 - 2023)

Haleon (HLN) EBITDA Margin Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Haleon 43.63 Bn 42.66 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.53 Bn 2.15 Bn -1,647.00
3 Zoetis 31.60 Bn 29.93 Bn 1.05 Bn -368.00
4 Takeda Pharmaceutical 28.74 Bn 22.95 Bn 5.10 Bn -17.00
5 United Therapeutics 22.36 Bn 19.70 Bn 683.80 Mn -341.00
6 Viatris 18.78 Bn 17.89 Bn 1.46 Bn -634.00
7 Neurocrine Biosciences 15.68 Bn 15.29 Bn 935.80 Mn -538.00
8 Elanco Animal Health 12.03 Bn 11.50 Bn 798.00 Mn 40.00
9 Dr Reddys Laboratories 10.08 Bn 9.91 Bn - -
10 Alkermes 8.27 Bn 7.62 Bn 397.90 Mn -2,010.00

Historic Data

Download Data
DateValue
Dec 31, 2023 -3,571.00
Dec 31, 2022 3,831.00